Old Web
English
Sign In
Acemap
>
authorDetail
>
C. Wang
C. Wang
Amgen
Osteoporosis
Zoledronic acid
Denosumab
Medicine
Internal medicine
3
Papers
132
Citations
0.00
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (3)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
Efficacy and safety of denosumab vs. bisphosphonates in postmenopausal women previously treated with oral bisphosphonates
2019
Osteoporosis International
Paul D. Miller
Nicola Pannacciulli
J. Malouf Sierra
A. Singer
Edward Czerwiński
Henry G. Bone
C. Wang
Shuang Huang
Arkadi A. Chines
Willem F. Lems
J. P. Brown
Show All
Source
Cite
Save
Citations (13)
Denosumab or Zoledronic Acid in Postmenopausal Women With Osteoporosis Previously Treated With Oral Bisphosphonates
2016
The Journal of Clinical Endocrinology and Metabolism
Paul D. Miller
Nicola Pannacciulli
Jacques P. Brown
E. Czerwiński
Bettina Nedergaard
Michael A. Bolognese
Jorge Malouf
Henry G. Bone
Jean-Yves Reginster
A. Singer
C. Wang
Rachel B. Wagman
Steven R. Cummings
Show All
Source
Cite
Save
Citations (118)
A randomized double-blind study of denosumab compared with zoledronic acid in postmenopausal women with osteoporosis previously treated with oral bisphosphonate.
2015
Arthritis & Rheumatism
Paul D. Miller
Nicola Pannacciulli
Jacques P. Brown
E. Czerwiński
Bettina Nedergaard
Bolognese
Jorge Malouf
Henry G. Bone
Jean-Yves Reginster
A. Singer
C. Wang
Rachel B. Wagman
Steve Cummings
Show All
Source
Cite
Save
Citations (1)
1